EPISODE · Nov 26, 2018 · 13 MIN
CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)
from Stock Day Media · host Stock Day Media
CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs. OTCQB: NXEN # pharmaceutical company # cannabinoid-based pharmaceuticals # U.S. Food and Drug Administration # Colorado # drug development strategy # FDA protocols # formerly INTIVA BioPharma # healthcare # Intellectual Property # Medical Marijuana # pre-clinical and clinical pathways Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs. OTCQB: NXEN # pharmaceutical company # cannabinoid-based pharmaceuticals # U.S. Food and Drug Administration # Colorado # drug development strategy # FDA protocols # formerly INTIVA BioPharma # healthcare # Intellectual Property # Medical Marijuana # pre-clinical and clinical pathways Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m